Option Care Health, Inc. $OPCH Shares Bought by Intech Investment Management LLC

Key Points

• Intech Investment Management LLC increased its stake in Option Care Health by 9.4%, holding a total of 120,192 shares valued at approximately $4.2 million.
• Analyst ratings for Option Care Health show a strong outlook, with an average rating of "Moderate Buy" and a target price of $35.75 from multiple brokerages.
• Company insiders have recently purchased a significant number of shares, indicating confidence in the business, with total insider purchases valued at over $1.6 million in the last quarter.

Intech Investment Management LLC raised its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 9.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 120,192 shares of the company's stock after buying an additional 10,368 shares during the period. Intech Investment Management LLC owned about 0.07% of Option Care Health worth $4,201,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after buying an additional 836 shares during the last quarter. Brooklyn Investment Group boosted its holdings in shares of Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after purchasing an additional 780 shares during the last quarter. Bessemer Group Inc. boosted its holdings in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after purchasing an additional 599 shares during the last quarter. Public Employees Retirement System of Ohio boosted its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares during the last quarter. Finally, Wealthquest Corp acquired a new position in shares of Option Care Health during the 1st quarter worth approximately $66,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently weighed in on OPCH. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities boosted their target price on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Finally, Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Trading Down 3.0%

OPCH opened at $28.48 on Friday. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The stock has a market capitalization of $4.62 billion, a PE ratio of 22.78, a P/E/G ratio of 1.79 and a beta of 0.82. The business's 50 day moving average price is $29.09 and its 200 day moving average price is $31.44. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling at Option Care Health

In other news, Director Norman L. Wright bought 3,411 shares of the business's stock in a transaction on Tuesday, September 9th. The shares were bought at an average price of $29.31 per share, with a total value of $99,976.41. Following the completion of the transaction, the director directly owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy P. Sullivan bought 20,000 shares of the business's stock in a transaction on Thursday, August 21st. The stock was purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the transaction, the director owned 49,229 shares of the company's stock, valued at $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 59,411 shares of company stock valued at $1,627,576 over the last quarter. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.